EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Dysregulated Serum miR-222-3p, miR-595, and miR-130a-3p as Potential Noninvasive Diagnostic Biomarkers for Papillary Thyroid Carcinoma

Shawnm Abdulah Ismail, Parween Abdulsamad Ismail

World Journal of Oncology · 2026-12 · 17 (6) · 898-911

DOI: 10.14740/wjon2858 ↗

Kurz gefasst

Fachartikel in der Zeitschrift World Journal of Oncology, 2026-12. Verfasst von Shawnm Abdulah Ismail und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Ismail, S. A., & Ismail, P. A. (2026). Dysregulated Serum miR-222-3p, miR-595, and miR-130a-3p as Potential Noninvasive Diagnostic Biomarkers for Papillary Thyroid Carcinoma. World Journal of Oncology, 17(6), 898-911. https://doi.org/10.14740/wjon2858

Vancouver

Ismail SA, Ismail PA. Dysregulated Serum miR-222-3p, miR-595, and miR-130a-3p as Potential Noninvasive Diagnostic Biomarkers for Papillary Thyroid Carcinoma. World Journal of Oncology. 2026;17(6):898-911. doi:10.14740/wjon2858

BibTeX
@article{Ismail2026,
  author = {Ismail, Shawnm Abdulah and Ismail, Parween Abdulsamad},
  title = {Dysregulated Serum miR-222-3p, miR-595, and miR-130a-3p as Potential Noninvasive Diagnostic Biomarkers for Papillary Thyroid Carcinoma},
  journal = {World Journal of Oncology},
  year = {2026},
  volume = {17},
  number = {6},
  pages = {898--911},
  doi = {10.14740/wjon2858}
}
Kostenlos starten →